Guy J M, Raynaud J, Gonthier R, Kimmerle L, Favre J P, Lamaud M, Cerisier A, Verneyre H
Service de Cardiologie, Hôpital Nord, St-Priest-en-Jarez.
Ann Cardiol Angeiol (Paris). 1993 Mar;42(3):121-6.
Coronary disease before the age of 40 has special clinical and pathogenic features. The authors sought evidence of the existence of abnormalities of hemostasis markers in 39 patients aged under 40, several weeks after a myocardial infarction (MI). Blood samples were drawn a mean of 8 months after the MI. These laboratory studies included assay of C and S proteins, fibrinogen, clotting factors VII and VIII and antithrombin III, as well as detection of any possible circulating anticoagulant. Plasma levels of platelet factor 4 (PT4) and of beta-thromboglobulin (BTG) were measured in the same sample, enabling determination of the BTG/PF4 ratio. Only fibrinogen and plasma levels of platelet proteins were abnormal, revealing a significant difference between patients with multi-vessel disease and those with single vessel disease or free of severe angiographic lesions. Platelet activation appeared to persist some time after the MI, chiefly in patients with multi-vessel disease, and showing no relation to either age or treatment. Conclusions require prudence in view of difficulties in interpreting plasma assays of PF4 and of BTG.
40岁之前的冠心病具有特殊的临床和致病特征。作者在39名40岁以下心肌梗死(MI)患者心肌梗死后数周,寻找止血标志物异常存在的证据。在心肌梗死后平均8个月采集血样。这些实验室研究包括检测C蛋白和S蛋白、纤维蛋白原、凝血因子VII和VIII以及抗凝血酶III,以及检测任何可能的循环抗凝剂。在同一样本中测量血小板因子4(PT4)和β-血小板球蛋白(BTG)的血浆水平,从而能够确定BTG/ PF4比值。只有纤维蛋白原和血小板蛋白的血浆水平异常,显示多支血管病变患者与单支血管病变患者或无严重血管造影病变患者之间存在显著差异。血小板活化似乎在心肌梗死后持续一段时间,主要见于多支血管病变患者,且与年龄或治疗均无关。鉴于PF4和BTG血浆检测结果解释存在困难,得出结论时需谨慎。